150 related articles for article (PubMed ID: 25722457)
21. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Buyukkaya E; Poyraz F; Karakas MF; Kurt M; Akcay AB; Akpinar I; Motor S; Turak O; Ozturk OH; Sen N; Akpek M; Kaya MG; Gibson CM
Am J Cardiol; 2013 Jul; 112(2):187-93. PubMed ID: 23601576
[TBL] [Abstract][Full Text] [Related]
22. Association of mean platelet volume with impaired myocardial reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Lai HM; Chen QJ; Yang YN; Ma YT; Li XM; Xu R; Zhai H; Liu F; Chen BD; Zhao Q
Blood Coagul Fibrinolysis; 2016 Jan; 27(1):5-12. PubMed ID: 26258675
[TBL] [Abstract][Full Text] [Related]
23. Predictors of myocardial functional recovery following successful reperfusion of acute ST elevation myocardial infarction.
Shehata IE; Cheng CI; Sung PH; Ammar AS; El-Sherbiny IAE; Ghanem IGA
Echocardiography; 2018 Oct; 35(10):1571-1578. PubMed ID: 30073720
[TBL] [Abstract][Full Text] [Related]
24. COmparison between COronary THrombus aspiration with Angiojet® or Export® catheter in patients with ST-elevation myocardial infarction submitted to primary angioplasty: The COCOTH Study.
Giglioli C; Cecchi E; Sciagrá R; Baldereschi GJ; Meucci F; Valente S; Chiostri M; Gensini GF; Spini V; Landi D; Romano SM; Calabretta R
Int J Cardiol; 2016 Jan; 203():757-62. PubMed ID: 26590366
[TBL] [Abstract][Full Text] [Related]
25. Trial design and rationale of TY-51924 as a novel Na+/H+ exchanger inhibitor in patients with ST-elevation acute myocardial infarction undergoing percutaneous coronary intervention.
Ishihara M; Asakura M; Kimura K; Nakao K; Hamada C; Hirayama A
J Cardiol; 2014 Jan; 63(1):82-7. PubMed ID: 23860273
[TBL] [Abstract][Full Text] [Related]
26. Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trial.
Prati F; Romagnoli E; Limbruno U; Pawlowski T; Fedele S; Gatto L; Di Vito L; Pappalardo A; Ramazzotti V; Picchi A; Trivisonno A; Materia L; Pfiatkosky P; Paoletti G; Marco V; Tavazzi L; Versaci F; Stone GW
Am Heart J; 2015 Dec; 170(6):1116-23. PubMed ID: 26678633
[TBL] [Abstract][Full Text] [Related]
27. Cytochrome c release in acute myocardial infarction predicts poor prognosis and myocardial reperfusion on contrast-enhanced magnetic resonance imaging.
Liu ZB; Fu XH; Wei G; Gao JL
Coron Artery Dis; 2014 Jan; 25(1):66-72. PubMed ID: 24077325
[TBL] [Abstract][Full Text] [Related]
28. Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings.
Campo G; Morciano G; Pavasini R; Bonora M; Sbano L; Biscaglia S; Bovolenta M; Pinotti M; Punzetti S; Rizzo P; Aquila G; Giorgi C; Ferrari R; Pinton P
Int J Cardiol; 2016 Oct; 221():993-7. PubMed ID: 27441480
[TBL] [Abstract][Full Text] [Related]
29. [Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].
Tomaszuk-Kazberuk A; Korecki J; Kochman W; Dobrzycki S; Musiał WJ
Przegl Lek; 2002; 59(8):638-41. PubMed ID: 12638338
[TBL] [Abstract][Full Text] [Related]
30. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M
Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334
[TBL] [Abstract][Full Text] [Related]
31. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
[TBL] [Abstract][Full Text] [Related]
32. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.
Fuernau G; Zaehringer S; Eitel I; de Waha S; Droppa M; Desch S; Schuler G; Adams V; Thiele H
Int J Cardiol; 2013 Sep; 167(5):2134-9. PubMed ID: 22704876
[TBL] [Abstract][Full Text] [Related]
33. Successful reperfusion for acute ST elevation myocardial infarction is associated with a decrease in WBC count.
Smit JJ; Ottervanger JP; Slingerland RJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gosselink AT; de Boer MJ; van 't Hof AW
J Lab Clin Med; 2006 Jun; 147(6):321-6. PubMed ID: 16750670
[TBL] [Abstract][Full Text] [Related]
34. Fever after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction is associated with adverse outcomes.
Cho HO; Nam CW; Lee HM; Shin HW; Cho YK; Yoon HJ; Park HS; Kim H; Chung IS; Hur SH; Kim YN; Kim KB
Int J Cardiol; 2014 Jan; 170(3):376-80. PubMed ID: 24290071
[TBL] [Abstract][Full Text] [Related]
35. Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size.
Wong DT; Leung MC; Das R; Liew GY; Teo KS; Chew DP; Meredith IT; Worthley MI; Worthley SG
Int J Cardiol; 2013 Apr; 165(1):61-6. PubMed ID: 21875755
[TBL] [Abstract][Full Text] [Related]
36. Operator versus core laboratory assessment of angiographic reperfusion markers in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction.
Brener SJ; Cristea E; Lansky AJ; Fahy M; Mehran R; Stone GW
Circ Cardiovasc Interv; 2012 Aug; 5(4):563-9. PubMed ID: 22828707
[TBL] [Abstract][Full Text] [Related]
37. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
[TBL] [Abstract][Full Text] [Related]
38. Endogenous serum erythropoietin and no-reflow in patients with ST-elevation myocardial infarction.
Niccoli G; Andreotti F; Marzo F; Cecchetti S; Santucci E; D'Amario D; Pafundi T; Cosentino N; Crea F
Eur J Clin Invest; 2011 Nov; 41(11):1210-9. PubMed ID: 21492156
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
40. Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial.
Dudek D; Dziewierz A; Brener SJ; Abizaid A; Merkely B; Costa RA; Bar E; Rakowski T; Kornowski R; Dressler O; Abizaid A; Silber S; Stone GW
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001484. PubMed ID: 25603802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
